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Summary; Despite a strong cytotoxic T-lymphocyte (CTL) response direc-
ted against viral antigens, untreated individuals infected with the human
immunocieficiency virus (HIV- ]) develop AIDS, We have found that pri-
mary T cells infected with HIV-1 downregulate surface MHC cUbs I anti-
gens and are resistant to lysis by HLA-A2-restricted CTL clones. In contrast,
cells infected with an HIV-1 in which the nef gene is disrupted are sensitive
to CTLs in an MHC and peptide-specific manner. In primary T cells
HLA-A2 antigens are downmodulated more dramatically than total MHC
class I antigens, suggesting that nef selectively downmodiilates certain
MHC class I antigens. In support of this, studies on ceils expressing indi-
vidual MHC class I alietes have revealed that nef does not downmodulate
HLA-C and HLA-E antigens, Tliis selective downmoduiation allows
Infected cells to maintain resistance to certain natural killer cells ihu lyse
infected cells expressing low levels of MHC class I antigens. Downmodu-
iation of MHC class I HLA-A2 antigens occurs not only in primary T cells,
but also in B and astrocytoma cell hnes. No effect of other HIV-1 accessory
proteins such as vpu and vpr was observed. Thus Nef is a protein that may
promote escape of HIV-1 from immune surveillance.
Introduction
A dramatic increase in onr knowledge of the natnral history of
human immttnodeficiency virus (HIV) infection has yielded
insights into mechanisms of HIV disease pathogenesis. After
exposure to HIV an infected individual becomes acutely
viremic. This phase subsequently resolves coincident with the
appearance of anti-HIV cytotoxic T lymphocytes (CTLs) (1, 2).
Thereafter infected individuals experience a period of clinical
latency that is variable in length and proportional to the
amount of circulating virus (3). It is not until much later, when
HIV has destroyed most of the host's CD4+ T cells, that the
infected individual becomes symptomatic with opportunistic
infections that the weakened immune system can no longer
contain. Coincident with the drop in CD4+ T cells and the
appearance of opportimistic infections, there is also a rise in
HIV loads presumably because the immune system completely
fails to contain HIV (4-6).
A shortened half life of infected CD4+ T cells has been
demonstrated both in vivo and in vitro and is due at least in part
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Collins & Baltimore • HIV immune evasion
[ Cytotoxic T Lymphocyte
Fig. I. Antigen processing and presentation in
association with MHC class I antigens. Schematic
diagram of cytotoxic T cells recogni.;ing a target
cell by contaci of the T-cell receptor and CDS
molecules with MHC class I antigens and
peptide antigen.
to the direct toxic effects of HIV (7-14). Additional destruction
may be mediated by the host's immune response against
infected cells. Thus a disease model has evolved in which viral
loads are maintained by successive rounds of newly infected
CD4'*' T cells that live just long enough to produce the next
round of viral progeny The precise contribution of sequestered
reservoirs and longer lived celts such as infected macrophages
has not yet been well worked out (for review see (15)),
In an infected individual multiple factors determine viral
levels including the effectiveness of the host's immune response
and the genetics of the particular infecting viral strain. In sup-
port of the importance of host factors, studies using MHC
class I HLA-tetrameric complexes to identify anti-HIV CTLs
have indicated an inverse correlation between the quantity of
anti-HIV CTLs and viral load (16). In addition, a role for CTLs
in controlling HIV-l infection in vivo is supported by individual
patient studies in which variant HIV epitopes appear to have
been selected by a strong immune response (17-19). These
studies suggest an important role for CTLs in the control of
virus load.
CTLs detect infected cells through the T-cell receptor and
CD8 molecules which recognize foreign peptides assembled in
the groove of MHC class I proteins and expressed on the surface
of almost all mammalian cells (Fig, 1). The peptides are derived
from cytosohc proteins which are digested by the proteasome
and transported into the endoplasmic reticulum where they
Fig. 2. Schematic diagram of antigen
processing and presentation in association
with MHC class I antigen heavy and light
chains. TAP: transporter associated with
antigen processing; ER: endopUsmic
reticulum.
assemble with the MHC class I heavy and light chains (Fig. 2),
In addition to this classical mode of CTL activation, CTLs can
also become activated by other routes: for instance, phagocytes
and dendritic cells can ingest antigens and present them in
association with MHC class I antigens (20-22).
CTLs are well known for their ability to lyse cells express-
ing foreign antigens by the release of granzymes and perforins
and by tbe activation of Fas-mediated killing (23). However
they may have more than one defense mechanism against HIV
In addition to the traditional cytolytic responses, activated anti-
HIV CTLs secrete soluble substances including chemokines that
potently inhibit infection by HIV (24-26). It is possible that
secretion of soluble inhibitory factors by CTLs plays an impor-
tant role in the control of virus levels. Consistent with this,
McMichael and colleagues reported a strong inverse correlation
between CTLs and viral load, but were unable to detect an
inverse correlation between CTLs and life span of infected cells
(16), Perhaps activated CTLs reduce viral loads by inhibiting
new infection with soluble factors, but fail to kill already
infected cells efficiently. The surviving cells would continue to
generate virus with variant antigens that could potentially
escape immune recognition. Such a model would help explain
why the potent anti-HIV CTL response fails to prevent progres-
sion to the acquired immunodeficiency syndrome (AIDS) in
almost every untreated individual.
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myristovlat ion acidic PXXP PXXP
Fig. 3. Conserved domains within the nef open reading frame.
Schematic diagram of the conserved domains of Nef (6 5, 66).
fig. 4. SchematicofHIV-PLAPgenome.Genomic organization of HIV-1
vectors containing FLAP. The HIV-PLAP vectors HXB-PI and HXB-EP were
derived from the molecular clone HXB2D. Like their parent, they do not
express functional vpu and vpr proteins. In addition, HXB-EP lacks a
functional envelope gene. The NL-PI vectors have a similar construction,
but were derived from the molecular clone NL4-3. NL-PI has open
reading frames for all accessory proteins. For detail on the construction
of these vectors, please refer to Chen et al. (32) and Collins et al. (33).
The critical role of viral determinants in the establishment
of high viral loads is best illustrated by the requirement of an
intact nef gene for the development of AIDS in humans and
monkeys (27-29). Nef is a 27-34 kDa myristoylated protein
that has several conserved domains which appear to be impor-
tant for its function (Fig. 3). Notably, there is a conserved acidic
domain of unclear function and several proline-rich domains.
The first proline-rich domain has been shown to be important
for ihe interaction of Nef with SH3 domain containing kinases
such as Hck (30). Cell culture studies have delineated multiple
activities of Nef including increased viral infectivity, T-cell acti-
vation, CD4 downmoduiation and MHC class I antigen down-
modulation (for review see (31)). It is still unclear whether all
the reported cell culture activities of nef are required for HIV
disease pathogenesis in infected people.
Role of Nef in protection of HIV-infected cells from CTLs
We recendy reported that expression of nef in an infected cell
protects it from anti-HIV CTL recognition. To infect primary
CD4+ T cells, we used an HIV that placed the cell surface marker
placental alkaline phosphatase (PLAP) on the infected cell (32),
(Fig. 4). Thus in a mixture of infected and uninfected cells we
were able to directly examine what happened to the infected
cells after adding CTLs. Specifically we used CTL clones
restricted to MHC class I HLA-A2 antigens and that recognized
the HXB Gag epitope (SLYNTIAVL (SL9)) (33). V ê found that
the ability of these CTLs to recognize and kill infected target
cells expressing nef was reduced up to 24-fold in some experi-
ments. Because of the importance of MHC class I antigens for
CTL recognition, we stained infected cells with anti-MHC
class I antibodies and found that infected cells expressing nef
had reduced levels of MHC class I antigens on their cell surface.
The loss of MHC class I antigens was dramatic, especially when
we used monoclonal antibodies specific to antigens encoded by
the MHC class IHLA-A2 allele (Fig. SA). A nef- HIV did not cause
downmoduiation of HLA-A2 and an A2- donor showed no
reactivity to the antibody (Fig. 5A).
We then demonstrated that the ability of CTLs to recognize
infected cells could be restored by preincubating infected cells
with synthetic peptide epitope (33). We were thus able to dem-
onstrate that HIV-infected cells escape CTL recognition by
reducing the density of antigenic peptide complexed to MHC
class I antigen on the celi surface. A partial reduction in surface
MHC class I antigen with HIV-1 infection has been reported
previously (25, 34, 35), and has been attributed variably to nef,
vpu and tot (36—38). Interestingly, the downregulation of MHC
class I HLA-A2 antigens we observed on primary T cells vifas
more dramatic than what had previously been reported. We
found that primary T cells infected with a nef+ virus had up to
300-fold less surface HLA-A2 by How cytometry. It is worth
noting that Tsomides et al. (39) demonstrated that there are
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Fig. S. Downmoduiation of MHC class I
antigens by HIV-1. Primary CD4+ T cells were
infected with HIV-PLAP and were stained with
the Indicated antibodies. A. Cells were stained
with monoclonal aniihodies speciOc for HLA-A2
(obtained from One Lambda) and a polyclonal
antihody against PLAP (obtained from Dako,
Zymcd or Biomeda). B. Cells were stained with
monoclonal antibody W6/32 (Hanlaxi) which
recognizes HLA-A, B and C antigens and a
polyclonal antibody against PLAP C. Cells were
stained witb a monoclonal antibody specific for
HLA-A2 antigens and a flourescein
isothiocyanate (FITC)-conjngated monoclonal
antibody that recognizes HIV-1 Gag, The FITC-
tonjugated anti-Gag antibody was KC57
(Coulter). Intracellular staining was as
described previously (25).
approximately 400 Gag SL9 epitopes presented on the surface
of Jurkat cells chronically infected with a virus lacking nef. Thus,
expression of nef may eliminate almost all Gag SL9 epitopes
from the surface of some infected cells.
When monoclonal antibodies were used that recognized
epitopes common to MHC class I HLA-A, B and G antigens,
downmoduiation was apparent, but was less impressive (com-
pare Figs SA and 5B). There are at least three possible explana-
tions for this phenomenon. One is that not all types of MHG
class I antigens are downmodulated. Another is that loss of
monoclonal antibody binding does ncn reflect loss of protein
from the cell surface, but rather loss of the monoclonal anti-
body epitope (as could occur from a conformational change).
A third is that this monoclonal antibody is not completely spe-
cific and recognizes antigens other than those related to MHC
class I HLA-A, B and G, in support of the first explanation,
Schwartz and colleagues have reported that when nef is ex-
pressed alone it is able to downmodulate exogenously ex-
pressed MHG class I HLA-A and HLA-B antigens, but not HLA-
C antigens (40). This is because HLA-G antigens lack a tyrosine
residue in their cytoplasmic tails that is required for nef-medi-
ated downmoduiation (40, 41). Consistent with the findings
of Schwartz and colleagues, we have not observed nef-mediated
protection of infected cells by HLA-Cw8-restricted CTLs
(K. L Collins, B. D, Walker. D. Baltimore, unpubhshed results). Ln
addition, selective nef-dependent downmoduiation of HLA-A
and -B antigens but not HLA-C or HLA-E antigens was observed
in HIV-infected 721,221 cells expressing individual MHC class I
genes (G. B. Cohen, R. T Gandhi. D. M. Davis, O. Mandelboim,
B. K. Chen, J. L. Strominger, D. Baltimore, unpublished results).
We have found it difficult to examine directly whether
endogenous HLA-G antigens on primary T cells are downmod-
ulated with HIV infection, due to the low level of MHC class 1
HLA-C antigens normally expressed on the surface of cells
(42-45) and due to the relative lack of commercially available
HLA-C-specific monoclonal antibodies. Although initial studies
led us to believe that HLA-Cw3 was downmodnlated in a nef-
dependent manner (33), this observation may have been due
to antibody cross-reactivity. HIV-mediated downmoduiation of
HLA-Gw3 is certainly less apparent when it is overexpressed in
721.221 cells (G. B. Gohen, K. T Gandhi, D. M. Davis, O. Mandel-
boim, B. K. Chen, J. L. Strominger, D. Baltimore, unpublished
results).
A rationale for the specificity of MHC class I downmodu-
iation is that HLA-A and -B are the major MHC class I encoded
proteins known to present antigens to CTLs while HLA-G and
-E can interact with various inhibitory receptors on natural kill-
er (NK) cells and can protect cells against these killers. Thus
HIV may direct its attention against the major subset of MHC
class I antigens that allow for CTL killing while sparing others
that might make the cells sensitive to NK-cell killing. In support
of this theory, infected 721.221 cells were resistant to certain
GTL and NK cells (G.B, Cohen, R. T Gandhi, D, M, Davis, O. Man-
delboim, B. K. Ghen, J. L. Strominger, D. Baltimore, itnpubiished
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nef vpu up, nef" vpu vpr
A2" donor
Fig. 6. Nef is required for MHC class I
downmodulafion whereas vpu and vpr
are not. Priiiury CD4* T LCUS were
infected with NL-PI coniaiiiiii^
mutacions in Def, vpu or vpr genes.
Infected ceils were then stained with
antibodies against HLA-A2 antigens and
against PLAP, A nnll mutation was
introduced in vpu hy using a PCR-ha.sed
approach to change the ATG tf) ACG, A
frameshift mutation was introduced
into vpr by filling in the Afl II site in the
vpr open reading frame. The mutant
containing both vpu and vpr mutations
was constructed by substituting the Sai
I-Spe I fragment of NLPIgag'̂ H-pu" with
the Sal I-Spe I fragment of NLPIgag'̂ v̂pr ,
All nef mutations were made by ablating
the N-termina! unique Xho I site (32,
33), The absence of the mutant protein
was confirmed for each by western blot.
— Log PLAP fluorescence
results). It is important to point out, however, that some NK
cells may require MHC class I HLA-B antigens for inhibition
(46), that there are anti-HIV-HLA-C-res trie ted CTL (47-49)
and that HLA-E can on some occasions activate NK cells (50),
All of our experiments were performed with cells infected
with a lab-adapted virus that expresses PLAP (Fig. 4). It will thus
be important to demonstrate that our results are generahzable
to cells infected with naturally occurring viruses or so-called
"primary isolates". As a first step towards this goal we asked
whether we could detect MHC class I antigen downmodulation
by staining cells for intracellular Gag rather than with PLAP.
Surprisingly we found that it was much more difficult to detect
the effects of nef using an intracellular stain. It is probably the
fixation process required for intracellular staining that makes
the experiment so unconvincing (Fig, 5C), The diminished abil-
ity to detect the effect of nef on MHC class I antigens with this
staining technique is consistent with what others have reported
(25). Although not useful for examining MHC class I antigen
downmodulation, staining with intracellular Gag was helpful
in confirming the abihty of PLAP expression to identify
infected cells. The percentage of PLAP positivity correlated
nicely with the percentage of cells positive for intracelluiar Gag,
The role of otber HIV accessory proteins
To explore the role of vpu and vpr in MHC class I downmodula-
tion and protection of infected cells from CTLs, we inserted
PLAP into a HIV-l molecular clone, NL-PI, which expresses
these genes (and contains many other variations in sequence
(33)). In NL-PI there are two amino acid changes within the
relevant gag epitope which result in non-recognition by the
anti-gag CTL clones described above (S, Kalams, manuscript in
preparation). Therefore, to create a version that could be recog-
nized by the CTL clones, the N-terminus of HXB-PI gag was
inserted into NL-PI (NL-PIgag™ (33)).
The results we obtained with NL-PIgag"™ were very similar
to what we observed with HXB-PI. Cells infected with NL-PI
depended on nef for MHC class I downregulation; there was no
more than twofold residual downregulation in the absence of a
functional nef gene. A CTL killing assay suggested tbat there
might be another protective factor in NL-PI because nef NL-PI
constructs survived better than nef- HXB constructs (40% versus
10% (33)),
To further explore the role of other HIV genes we con-
structed mutants in NL-PIgagHXB that did not express vpti
ImmunoiogicQi Reviews 168/1999 69
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Fig. 7. HIV-1 Nef protects infected cells from CTLs,
but Vpu and Vpr do not. Primary CD4+ T cells vi'-ere
infected with the indicated virus and were then treated
with CTL clone ! 61JXA14 as described (33), All cells
were then stained with antibodies against HLA-A2
antigens, PLAP and CD8, Surviving CDS" cells were
identified as described (i) and the percentage of
surviving cells was quantitated; [(percentage PLAP* in
CTL-treated sample)/ (the average percentage PLAP*
of duplicates to which no CTLs were added)] x 100.
HXBnef-A2- refers to target cells isolated from an HLA-
A2-negative donor and infected with HXB-PInef-. All
other cells were isolated from an HLA-A2-positive
donor. NL-PIntf refers lo a virus that lacks the cognate
epitope recognized by the CTL clones (33), The
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Fij. 8. Time course of MHC class 1 downmodulaiion.
Primary CD4* T lymphocytes were infected with HIV PLAP,
harvested at (A) 24. (B) 48 and (C) 72 h post-infection and
stained with antibodies directed against HLA-A2 antigens and
PLAP
and/or vpr. In contrast with the dramatic effect of nef, we
observed no significant effect of vptj and vpr expression on MHC
class I downmodulation (Fig. 6). Additionally, we were unable
to detect any effect of vpu and/or vpr expression on the ability of
CTLs to recognize and lyse infected primary T cells that did not
express nef (Fig. 7). Most of our work is based on HLA-A2-
restricted CTLs recognizing a Gag epitope and we cannot rule
out an effect of these genes on other MHC class I antigens and
on the ability of CTLs to recognize other viral antigens.
Timing of MHC class I antigen downmodulation
All of our CTL assays were performed by mixing CTLs with tar-
get cells that had already been infected for at least 48 h. This
system differs from the in vivo situation where CTLs are contin-
uously exposed to virally infected cells at all stages of infection.
To determine whether there might be a window of time before
MHC class 1 downmodulation occurs when CTLs could recog-
nize infected cells, we performed a time course in wbich cells
were sarnpled and stained at varying times after infection. We
found that at 24 h, we could just begin to see PLAP staining and
downmodulation of MHC class I antigens (Fig. 8.4), By 48 h we
could detect brightly staining PLAP-positive cells and complete
downmodulation of MHC class I antigens (Fig. 8B). We have
observed on multiple occasions that Nef is fully active in pro-
tecting infected cells as early as 48 h post-infection (data not
shown). However, due to the lack of PLAP staining, we have not
been able to test the efficacy of CTLs earher than 48 b post-
infection.
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Fig. 9. MHC class I downmoduiation occurs in
infected astrocytoma cells and B cells. The lY
EBV-transformed B-cell line (39) and 373MG
astrocytoma tells (67) were infected with an
HIV-1 molecular clone (HXB-EP (33))
pseudotyped with VSV-G (68), Forty-eight hours
post-infection cells were harvested and stained
with antibodies directed against HLA-A2 antigens
and PLAP
Effect of nef on MHC class I antigens expressed
by other cell types
To examine whether the effect of nef on MHC class I antigens
extends to cell types that lacked the required HIV receptors, we
used an envelope-defective form of HIV pseudotyped with
vesicular stomatitis virus G protein (VSV-G). An Epstein-Barr
virus (EBV)-transformed B-cell hne (JY cells) and an astrocy-
toma cell line (373 MG) were infectable with the VSV-G
pseudotyped virus (Figs 9A & 9B). We found that HIV expressing
nef dramatically downmodulated MHC class I HLA-A2 antigens
on both cell lines in a nef-dependent manner. Interestingly, both
cell lines express higher levels of HLA-A2 antigens than primary
T cells, and nef leaves a correspondingly higher residual amount
of MHC class I antigens on these cells. It will be important to
determine whether related cell types such as primary macro-
phages important for infection in vivo similarly have high residual
MHC class I antigens. If true, these cells may be more susceptible
to CTLs than the primary CD4"̂  T cells we have tested thus far.
Interestingly, macrophages have recently been shown to be
important for high viral loads in end stage individuals with low
CD4 cotmts (and presumably poor GTL function) (51).
Closing remarks
The development of the HIV PLAP system has provided us with
a unique probe to better understand HIV-induced disease
pathogenesis. Using this approach various groups in the Balti-
more laboratory have demonstrated the independent contribu-
tions of nef, vpu and env genes in the downmoduiation of GD4
(32), the role of nef in protecting primary T cells from CTLs
(33), the direct toxicity of HIV on T cells (14) and the ability of
NK cells to recognize Lnfected cells (G. B. Gohen, R. T. Gandhi,
D. M. Davis, O. Mandelboim, B. K. Ghen, J. L. Strominger, D. Balti-
more, unpublished results). The benefit of this marker over
staining methods that rely on fixation and permeabihzation is
evident in the work presented here.
The mechanism of Nef-mediated MHC class I dow^nmodu-
lation is currently being explored by a number of groups and is
gradually coming to light. Interestingly, it appears that different
domains of nef are required for MHC class I dowTimodulation
versus nef-mediated CD4 downmoduiation. Recent data has im-
plicated the acidic and proline-rich regions of nef as being im-
portant for MHC class I downmoduiation (41), whereas we
have not found the proline-rich region to be important for CD4
downmoduiation (30). Additional evidence supporting a sep-
arate mechanism for MHG class I antigen downmoduiation is
that expression of nef leads to localization of CD4 molecules to
membrane-associated clathrin-coated pits (52), whereas Nef
directs MHC class I antigens to the trans-Golgi (40, 41). How a
single 27 kDa protein mediates the downmoduiation of two
very different cell surface molecules by two different mecha-
nisms will be very interesting to learn. Nef has been reported
to interact with a host of cellular factors and it is possible that
nef's differential association with these factors is important for
its multiple activities. Three different cellular factors have now-
been imphcated in GD4 downmoduiation based on mutagene-
sis studies: a thioesterase (53) (G. B. Cohen, D. Baltimore, un-
published results), the u subunit of a clathrin adaptor (40, 54)
and a vacuolar ATPase (55). However, none have yet been di-
rectly implicated in MHG class I downmoduiation. A greater
understanding of the relevant cellular partners will belp speed
the development of effective anti-nef pharmaceuticals. Hopeful-
ly these would help control virus infection by allowing the
host's immune system to be more effective.
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Our studies demonstrate that nef-mediated MHG class I
dowai modulation can be profound and that nef-exprcssing cells
with low levels of MHC class I antigens have a survival advan-
tage in the presence of CTLs. Based on these findings we expect
that Nef-expressing cells will survive longer in vivo, produce
more infectious viral particles, and expose the immune system
to a greater diversity of antigenic variants. Thus the activity of
nef is likely to be synergistic with other reported mechanisms of
HIV escape from GTLs that rely on antigenic variation.
A growing number of studies suggest that antigenic varia-
tion is an important element of HIV immune evasion. Individ-
ual patients with immunodominant GTL responses can escape
the GTL response by generating antigenic variants not recog-
nized by CTLs (17-19). In addition, some individuals who
mount a CTL response to the immunodominant strain appear
to lack the ability to respond to immunogenic variants that
arise later (56-58). Furthermore, it has been reported that cer-
tain types of peptides that are sequence variants of the cognate
peptide antigens recognized by antigen-specific T-cell recep-
tors can act as antagonists (59, 60).
The effects of nef are likely to be aided by other mechanisms
that diminish the anti-HIV CTL response. Macrophages (and
possibly T cells) can directly kill some anti-HIV CTLs (61, 62).
In addition, preferential depletion of anti-HIV GD4+ T cells
probably leads to anti-HIV CTL anergy because of a lack of
T-cell help (63, 64). It is also probable that reservoirs of HIV-
infected cells exist that are sequestered in sites where access to
CTL is restricted, such as the brain. Finally truly latent cells
with integrated provirus that does not express viral proteins are
hkely to be resistant to CTL (for review see (15)). It is not sur-
prising that HIV employs multiple mechanisms to evade the
host's immune system given the almost universal lethality of
virus infection in untreated individuals. Hopefully a greater
understanding of precisely how the immune system is weak-
ened will provide ways of designing more effective therapeutics
and better vaccination strategies.
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